Sorted By:


New Study: Substantial rebates negotiated in Medicare Part D

PhRMA  |  Blog Post

This report is further evidence of the robust negotiating power of Part D plans and how they secure rebates and discounts to keep costs low for beneficiaries and taxpayers.

New Medicines Made Available through PDUFA

PhRMA  |  Graphic

The Prescription Drug User Fee Act (PDUFA) has helped bring more than 1,500 new safe and effective medications to patients.

Welcome to the new

PhRMA  |  Blog Post

Explore PhRMA’s new digital home at

What they are saying about new hepatitis C cure: “That's actually a great deal”

PhRMA  |  Blog Post

That's actually a great deal.

World AIDS Day: Making progress

PhRMA  |  Blog Post

On average, it costs $2.6 billion and takes between 10 to 15 years to bring a new medicine to patients.

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.

The Value Collaborative: Advancing private market solutions to achieve better health, lower costs

PhRMA  |  Blog Post

That is why we have proposed commonsense policy solutions to address the legal and regulatory barriers that currently exist and why we, as an industry, are investing in the development and use of tools for better measurement of outcomes and the creation of value frameworks that keep the needs of the patient in mind.

World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

PhRMA  |  Blog Post

If you’re looking to get involved in World Cancer Day, share this post or the videos and be sure to use the hashtags #WorldCancerDay and #NotBeyondUs to help spread the world about how innovative cancer medicines are enabling people to take back their lives.

Study highlights negative impact of Canada's promise doctrine on R and D investment

PhRMA  |  Blog Post

For more information on Canada’s promise doctrine and its overall approach to IP, go to

How Does Health Insurance Cover Your Medicines?

PhRMA  |  Video

This video explains some key points that help navigate coverage, including formularies and medicine tiers.

Exploring the new era of medicine

PhRMA  |  Blog Post

To learn more about the positive impact of the work being done by America’s biopharmaceutical companies, visit

Medicare Monday: Happy Memorial Day!

PhRMA  |  Blog Post

Get instant updates on issues you care about - here.

PhRMA: Propuesta de Clinton Volvería Atrás el Reloj en la Innovación Médica

PhRMA  |  Press Release

• Arriesga la seguridad del paciente al permitir la importación de medicamentos desde el extranjero sin evidencia de ahorros.

State Leaders See Bioscience as Jobs Engine

PhRMA  |  Blog Post

Indiana labor, business and policy leaders get it.

Patients showcase longer, healthier lives in new “From Hope to Cures” ads

PhRMA  |  Blog Post

Learn more here about the campaign and how America’s biopharmaceutical companies are driving innovation, collaborating and helping to translate new findings into hope for America’s patients.

Pharmaceutical Organizations Announce Key Principles to Foster Supply Chain Security and Integrity

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested over $500 billion in the search for new treatments and cures, including an estimated $49.5 billion in 2011 alone.

Burden on patients: Access to medicines in health insurance exchange plans

PhRMA  |  Blog Post

Multiple sclerosis (MS): While coverage is improving, more than one-third (36 percent) of marketplace plans still place all innovator brand MS medicines on the specialty tier.

340B Spotlight: Trends in shifting site of care

PhRMA  |  Blog Post

Learn more about policy solutions to address market distortions here

Boston Kickoff: The New Era of Medicine

PhRMA  |  Video

The event was the first in a national dialogue series PhRMA is supporting as part of its new GOBOLDLY campaign.

Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines

PhRMA  |  Blog Post

Learn more about Medicare Part D here.

World Asthma Day: New Hope for Millions with Asthma

PhRMA  |  Blog Post

PhRMA’s From Hope to Cures has resources dedicated to increasing awareness about asthma as well as information about new treatments targeting this chronic condition.

Cancer treatments got gentler, yet kids’ survival improved

From Hope To Cures  |  From Our Network

"We have actually reduced treatment, reduced therapy," and yet improved survival, he said.

A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements

PhRMA  |  Blog Post

Both New World and Together illustrate the incredible innovation happening in medical science and how industry scientists are changing the way we treat the most complex and debilitating diseases.

Part D

PhRMA  |  From PhRMA

Another testament to Part D’s success: about 90 percent or more of beneficiaries are satisfied with the program.

Medicines in Development for Arthritis 2014 Report

PhRMA  |  Report

New medicines today in the research and development pipeline offer hope of reducing the human and economic costs of the many musculoskeletal disorders affecting Americans.

You have reviewed the first 125 results out of 1960. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next